Navigation Links
DuPont Responds to Spelter, W.Va. Lawsuit Rulings

Company Will Appeal to State Supreme Court

WILMINGTON, Del., Feb. 26 /PRNewswire-FirstCall/ -- The following statement is in response to the rulings in the Spelter, W.Va., zinc smelter class action lawsuit late Monday. The statement is to be attributed to DuPont General Counsel Stacey J. Mobley.

"We are extremely disappointed by the rulings in the Spelter case. DuPont will appeal this case, including the recent rulings and the earlier jury verdicts. We believe there were numerous errors, both during and after trial, that deprived the company of a fair outcome in this case. We are hopeful that the Supreme Court of Appeals of West Virginia will grant review.

"The scientific evidence simply does not warrant medical monitoring. We believe the evidence presented both at trial and in the post-trial proceedings shows that there is no increased risk of disease to the class members as a result of the smelter.

"The court's decision to include biennial chest CT scans in the medical monitoring program is particularly troubling. CT scans are not recommended for such medical monitoring because the risks of harm, including risks of cancer due to radiation exposure, outweigh any benefits. This determination is supported by a recent study published in the New England Journal of Medicine. The trial evidence showed that neither the U.S. Preventive Services Task Force, nor any other authoritative medical screening authority, recommends CT scans for screening asymptomatic patients. The court's rulings, which adopt a plan that includes regular CT scans, ignore the consensus of the medical community.

"The court also erred in estimating the cost of the medical monitoring program at $130 million. Plaintiffs' counsel presented a grossly inflated cost projection as justification for a larger award of attorneys' fees. This estimate is based on implausible and inflated assumptions and forecasts about medical costs and participation rates for the class members. This projection overestimates the reasonable expected cost of the program by many tens of millions of dollars. DuPont's funding obligations will be based on the actual cost of the program, not plaintiffs' unrealistic estimate."

DuPont (NYSE: DD) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DuPont Pledges $1 Million to World Food Prize
2. DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity
3. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
4. DuPont Announces Leadership Changes
5. DuPont Opens Fluoropolymer Production Plant in China
6. DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker
7. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
8. DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber
9. DuPont Names Phuong Tram Chief Information Officer
10. DuPont Group Vice President Briefs Investors on Performance Materials Segment
11. DuPont Responds to Spelter, W.Va., Lawsuit Decision
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... StatRad , ... added Chris Hafey and Claude Hooton to its board of directors. The announcement ... America (RSNA) 2015 Annual Meeting and continues to strategically transform its focus from ...
(Date:11/28/2015)... ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. EST, ... With possible savings of up to 20% off orders $80 or more to free gifts ... every few hours. , As a competitive e-commerce website for skin care and cosmetic needs, ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... meeting in Washington D.C. revolved around the fact that proper dental care, both at-home ... stressed the link between periodontal disease (more commonly referred to as gum disease) and ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... affecting the health care in America. As people age, more care is needed, ... costs are rising, and medical professionals are being overworked. The forgotten part of ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ... which demands kidney transplantation is expected to boost the market ... for organ transplantation. --> 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ...
(Date:11/26/2015)... November 26, 2015 ... universitetssjukhus ser potential att använda SyMRI för ... för patienter med multipel skleros (MS) ... med SyntheticMR AB för att kunna använda ... sjukhuset. Med SyMRI kan man generera flera ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Italian ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
Breaking Medicine Technology: